Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0097242,GO:0097242,amyloid-beta clearance,4/20,39/18800,7.47817732071583e-08,8.82221328515752e-05,3.54747008319739e-05,IFNGR1/MSR1/TNF/TREM2,4
GO:0002274,GO:0002274,myeloid leukocyte activation,6/20,232/18800,1.11041073444399e-07,8.82221328515752e-05,3.54747008319739e-05,CSF1/HAVCR2/IFNGR1/LTBR/TNF/TREM2,6
GO:0150076,GO:0150076,neuroinflammatory response,4/20,73/18800,9.6691408576585e-07,0.0004177396638203,0.0001679758709144,IFNGR1/MMP3/TNF/TREM2,4
GO:1900221,GO:1900221,regulation of amyloid-beta clearance,3/20,20/18800,1.16023838933654e-06,0.0004177396638203,0.0001679758709144,IFNGR1/TNF/TREM2,3
GO:0045672,GO:0045672,positive regulation of osteoclast differentiation,3/20,24/18800,2.05434898612391e-06,0.0004177396638203,0.0001679758709144,CSF1/TNF/TREM2,3
GO:0048143,GO:0048143,astrocyte activation,3/20,24/18800,2.05434898612391e-06,0.0004177396638203,0.0001679758709144,IFNGR1/TNF/TREM2,3
GO:0002573,GO:0002573,myeloid leukocyte differentiation,5/20,210/18800,2.24264933972573e-06,0.0004177396638203,0.0001679758709144,CSF1/EPHA2/LTBR/TNF/TREM2,5
GO:1902993,GO:1902993,positive regulation of amyloid precursor protein catabolic process,3/20,25/18800,2.33290409594969e-06,0.0004177396638203,0.0001679758709144,IFNGR1/SPON1/TNF,3
GO:0002685,GO:0002685,regulation of leukocyte migration,5/20,218/18800,2.6939713563316e-06,0.0004177396638203,0.0001679758709144,CCL7/CCN3/CSF1/TNF/TREM2,5
GO:0030316,GO:0030316,osteoclast differentiation,4/20,96/18800,2.90515037359142e-06,0.0004177396638203,0.0001679758709144,CSF1/EPHA2/TNF/TREM2,4
GO:0032642,GO:0032642,regulation of chemokine production,4/20,97/18800,3.02803662212096e-06,0.0004177396638203,0.0001679758709144,EPHA2/HAVCR2/TNF/TREM2,4
GO:0032602,GO:0032602,chemokine production,4/20,98/18800,3.15473629065084e-06,0.0004177396638203,0.0001679758709144,EPHA2/HAVCR2/TNF/TREM2,4
GO:1901222,GO:1901222,regulation of NIK/NF-kappaB signaling,4/20,110/18800,5.00082172058798e-06,0.0005675932652867,0.000228232991308,CCN3/HAVCR2/TNF/TREM2,4
GO:1902226,GO:1902226,regulation of macrophage colony-stimulating factor signaling pathway,2/20,4/18800,6.44299221233594e-06,0.0006398696640876,0.0002572958074268,CSF1/TREM2,2
GO:0150077,GO:0150077,regulation of neuroinflammatory response,3/20,41/18800,1.06957624068512e-05,0.0009997392037933,0.0004020017201831,MMP3/TNF/TREM2,3
GO:0014009,GO:0014009,glial cell proliferation,3/20,44/18800,1.32614120838591e-05,0.0010124453523965,0.0004071109462453,CSF1/TNF/TREM2,3
GO:0070372,GO:0070372,regulation of ERK1 and ERK2 cascade,5/20,311/18800,1.51665683646583e-05,0.0010298820872586,0.0004141223722076,CCL7/EPHA2/HAVCR2/TNF/TREM2,5
GO:1903969,GO:1903969,regulation of response to macrophage colony-stimulating factor,2/20,6/18800,1.60869242199568e-05,0.0010298820872586,0.0004141223722076,CSF1/TREM2,2
GO:1905952,GO:1905952,regulation of lipid localization,4/20,155/18800,1.94295280467914e-05,0.0010837615180632,0.0004357876462948,MSR1/SPP1/TNF/TREM2,4
GO:0002269,GO:0002269,leukocyte activation involved in inflammatory response,3/20,50/18800,1.95460410947993e-05,0.0010837615180632,0.0004357876462948,IFNGR1/TNF/TREM2,3
GO:0002925,GO:0002925,positive regulation of humoral immune response mediated by circulating immunoglobulin,2/20,7/18800,2.25073191290672e-05,0.0010837615180632,0.0004357876462948,TNF/TREM2,2
GO:0010883,GO:0010883,regulation of lipid storage,3/20,55/18800,2.60741772059493e-05,0.0010903123047435,0.0004384217607759,MSR1/TNF/TREM2,3
GO:1904645,GO:1904645,response to amyloid-beta,3/20,55/18800,2.60741772059493e-05,0.0010903123047435,0.0004384217607759,MMP3/TNF/TREM2,3
GO:0034205,GO:0034205,amyloid-beta formation,3/20,56/18800,2.75313897589461e-05,0.0011217276494093,0.0004510540778321,IFNGR1/SPON1/TNF,3
GO:1903078,GO:1903078,positive regulation of protein localization to plasma membrane,3/20,60/18800,3.38950580616007e-05,0.0012823630299972,0.0005156466226413,EPHA2/TNF/TREM2,3
GO:0050900,GO:0050900,leukocyte migration,5/20,384/18800,4.17003270727402e-05,0.0015059504481496,0.0006055525964869,CCL7/CCN3/CSF1/TNF/TREM2,5
GO:0061517,GO:0061517,macrophage proliferation,2/20,12/18800,7.05118585490131e-05,0.0020323476519345,0.0008172203800631,CSF1/TREM2,2
GO:0032102,GO:0032102,negative regulation of response to external stimulus,5/20,429/18800,7.06037223135296e-05,0.0020323476519345,0.0008172203800631,CCN3/HAVCR2/SPP1/TNF/TREM2,5
GO:1903201,GO:1903201,regulation of oxidative stress-induced cell death,3/20,77/18800,7.16245868523201e-05,0.0020323476519345,0.0008172203800631,MMP3/TNF/TREM2,3
GO:0032103,GO:0032103,positive regulation of response to external stimulus,5/20,442/18800,8.13119357135129e-05,0.0021343607247024,0.0008582405086909,CCL7/CSF1/HAVCR2/TNF/TREM2,5
GO:0050920,GO:0050920,regulation of chemotaxis,4/20,225/18800,8.32519901781653e-05,0.0021343607247024,0.0008582405086909,CCL7/CCN3/CSF1/TREM2,4
GO:0036005,GO:0036005,response to macrophage colony-stimulating factor,2/20,13/18800,8.32790213540285e-05,0.0021343607247024,0.0008582405086909,CSF1/TREM2,2
GO:0045785,GO:0045785,positive regulation of cell adhesion,5/20,446/18800,8.48471202829959e-05,0.0021400329226933,0.0008605213368718,CD276/CSF1/HAVCR2/PLAUR/TNF,5
GO:0036473,GO:0036473,cell death in response to oxidative stress,3/20,98/18800,0.0001468178821746,0.003240189094104,0.0013029013812866,MMP3/TNF/TREM2,3
GO:1902882,GO:1902882,regulation of response to oxidative stress,3/20,101/18800,0.0001605397993742,0.0032752415409572,0.0013169962010937,MMP3/TNF/TREM2,3
GO:0002281,GO:0002281,macrophage activation involved in immune response,2/20,18/18800,0.0001628345385372,0.0032752415409572,0.0013169962010937,HAVCR2/TREM2,2
GO:0050830,GO:0050830,defense response to Gram-positive bacterium,3/20,104/18800,0.0001750705633087,0.0033925259158242,0.0013641570209037,EPHA2/HAVCR2/TNF,3
GO:0010744,GO:0010744,positive regulation of macrophage derived foam cell differentiation,2/20,19/18800,0.0001818754404832,0.0034000008815041,0.0013671627538491,CSF1/MSR1,2
GO:0031645,GO:0031645,negative regulation of nervous system process,2/20,19/18800,0.0001818754404832,0.0034000008815041,0.0013671627538491,CCN3/TNF,2
GO:0097193,GO:0097193,intrinsic apoptotic signaling pathway,4/20,295/18800,0.0002360133664964,0.0040607548328954,0.0016328562707876,EPHA2/PLAUR/TNF/TREM2,4
GO:2000810,GO:2000810,regulation of bicellular tight junction assembly,2/20,22/18800,0.000245221501489,0.0040607548328954,0.0016328562707876,EPHA2/TNF,2
GO:0060444,GO:0060444,branching involved in mammary gland duct morphogenesis,2/20,23/18800,0.0002684046182591,0.004351989167488,0.0017499635153954,CSF1/EPHA2,2
GO:0030198,GO:0030198,extracellular matrix organization,4/20,307/18800,0.0002747793249593,0.0044091577127731,0.0017729513640842,COL9A1/KLK4/MMP3/TNF,4
GO:0043062,GO:0043062,extracellular structure organization,4/20,308/18800,0.0002782044008433,0.0044091577127731,0.0017729513640842,COL9A1/KLK4/MMP3/TNF,4
GO:0045229,GO:0045229,external encapsulating structure organization,4/20,310/18800,0.000285146806412,0.0044091577127731,0.0017729513640842,COL9A1/KLK4/MMP3/TNF,4
GO:0022612,GO:0022612,gland morphogenesis,3/20,123/18800,0.0002872075458872,0.0044091577127731,0.0017729513640842,CSF1/EPHA2/TNF,3
GO:0002922,GO:0002922,positive regulation of humoral immune response,2/20,24/18800,0.0002926182791021,0.0044091577127731,0.0017729513640842,TNF/TREM2,2
GO:0060326,GO:0060326,cell chemotaxis,4/20,315/18800,0.0003030486339946,0.0045004138263319,0.0018096460485465,CCL7/CCN3/CSF1/EPHA2,4
GO:0050768,GO:0050768,negative regulation of neurogenesis,3/20,140/18800,0.0004199137740676,0.0059048051946329,0.0023743610699494,SPP1/TNF/TREM2,3
GO:0032946,GO:0032946,positive regulation of mononuclear cell proliferation,3/20,143/18800,0.0004467844859096,0.0061201771388831,0.0024609635476148,CD276/CSF1/HAVCR2,3
GO:0043032,GO:0043032,positive regulation of macrophage activation,2/20,30/18800,0.0004594299501811,0.0061867304308287,0.002487725064763,HAVCR2/TREM2,2
GO:0051961,GO:0051961,negative regulation of nervous system development,3/20,145/18800,0.0004652989322085,0.0062131092712555,0.0024983321702839,SPP1/TNF/TREM2,3
GO:0001818,GO:0001818,negative regulation of cytokine production,4/20,363/18800,0.0005184738833861,0.0068232678425465,0.0027436809515589,EPHA2/HAVCR2/TNF/TREM2,4
GO:2001233,GO:2001233,regulation of apoptotic signaling pathway,4/20,370/18800,0.0005571369636026,0.0070823250813165,0.0028478495739519,LTBR/PLAUR/TNF/TREM2,4
GO:0002495,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,2/20,34/18800,0.0005909965110583,0.0072797942331142,0.0029272532208276,IFI30/TREM2,2
GO:0010742,GO:0010742,macrophage derived foam cell differentiation,2/20,38/18800,0.0007387025029754,0.0088255509566008,0.0035488121828735,CSF1/MSR1,2
GO:0002822,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3/20,173/18800,0.0007780183481562,0.0089598417674018,0.003602811402612,HAVCR2/TNF/TREM2,3
GO:0002706,GO:0002706,regulation of lymphocyte mediated immunity,3/20,175/18800,0.0008043843204271,0.0091870952821464,0.0036941915380496,HAVCR2/TNF/TREM2,3
GO:0010721,GO:0010721,negative regulation of cell development,3/20,181/18800,0.0008868851746115,0.0091870952821464,0.0036941915380496,SPP1/TNF/TREM2,3
GO:0001503,GO:0001503,ossification,4/20,420/18800,0.000895609595578,0.0091870952821464,0.0036941915380496,CSF1/EPHA2/SPP1/TNF,4
GO:0002683,GO:0002683,negative regulation of immune system process,4/20,425/18800,0.0009359711664546,0.0091870952821464,0.0036941915380496,CCN3/HAVCR2/TNF/TREM2,4
GO:0031099,GO:0031099,regeneration,3/20,188/18800,0.0009897245749474,0.0091870952821464,0.0036941915380496,CCN3/SPP1/TNF,3
GO:1904646,GO:1904646,cellular response to amyloid-beta,2/20,45/18800,0.0010356457028549,0.0091870952821464,0.0036941915380496,TNF/TREM2,2
GO:0034151,GO:0034151,regulation of toll-like receptor 6 signaling pathway,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,TREM2,1
GO:0045994,GO:0045994,positive regulation of translational initiation by iron,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,TNF,1
GO:0048673,GO:0048673,collateral sprouting of intact axon in response to injury,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,SPP1,1
GO:0048683,GO:0048683,regulation of collateral sprouting of intact axon in response to injury,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,SPP1,1
GO:0048685,GO:0048685,negative regulation of collateral sprouting of intact axon in response to injury,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,SPP1,1
GO:0060034,GO:0060034,notochord cell differentiation,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,EPHA2,1
GO:0060035,GO:0060035,notochord cell development,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,EPHA2,1
GO:0060611,GO:0060611,mammary gland fat development,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,CSF1,1
GO:0061048,GO:0061048,negative regulation of branching involved in lung morphogenesis,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,TNF,1
GO:0070392,GO:0070392,detection of lipoteichoic acid,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,TREM2,1
GO:0140460,GO:0140460,response to Gram-negative bacterium,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,TNF,1
GO:1905805,GO:1905805,excitatory synapse pruning,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,TREM2,1
GO:1905806,GO:1905806,regulation of synapse pruning,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,TREM2,1
GO:1905808,GO:1905808,positive regulation of synapse pruning,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,TREM2,1
GO:2000350,GO:2000350,positive regulation of CD40 signaling pathway,1/20,1/18800,0.001063829787234,0.0091870952821464,0.0036941915380496,TREM2,1
GO:0010876,GO:0010876,lipid localization,4/20,446/18800,0.0011196566298987,0.0095968856218018,0.0038589709333468,MSR1/SPP1/TNF/TREM2,4
GO:0001763,GO:0001763,morphogenesis of a branching structure,3/20,199/18800,0.0011661310596202,0.0098041389086592,0.0039423088453884,CSF1/EPHA2/TNF,3
GO:0033674,GO:0033674,positive regulation of kinase activity,4/20,476/18800,0.0014243267613336,0.0115098455310905,0.0046281847155588,CSF1/EPHA2/TNF/TREM2,4
GO:0002931,GO:0002931,response to ischemia,2/20,53/18800,0.0014342035337671,0.0115098455310905,0.0046281847155588,CSF1/TREM2,2
GO:0034381,GO:0034381,plasma lipoprotein particle clearance,2/20,53/18800,0.0014342035337671,0.0115098455310905,0.0046281847155588,MSR1/TREM2,2
GO:0002764,GO:0002764,immune response-regulating signaling pathway,4/20,482/18800,0.001491596354078,0.0119102844554272,0.0047892038451487,CD276/HAVCR2/TNF/TREM2,4
GO:0060135,GO:0060135,maternal process involved in female pregnancy,2/20,58/18800,0.0017149472569119,0.0134238974937592,0.0053978376196295,HAVCR2/SPP1,2
GO:0071219,GO:0071219,cellular response to molecule of bacterial origin,3/20,229/18800,0.0017447216816851,0.0135900134911649,0.0054646339565679,HAVCR2/TNF/TREM2,3
GO:0046883,GO:0046883,regulation of hormone secretion,3/20,231/18800,0.0017886133256673,0.0136807391261934,0.0055011153321184,CCN3/SPP1/TNF,3
GO:0001649,GO:0001649,osteoblast differentiation,3/20,241/18800,0.002018475169918,0.0136807391261934,0.0055011153321184,EPHA2/SPP1/TNF,3
GO:0002037,GO:0002037,negative regulation of L-glutamate import across plasma membrane,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TNF,1
GO:0002582,GO:0002582,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TREM2,1
GO:0002585,GO:0002585,positive regulation of antigen processing and presentation of peptide antigen,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TREM2,1
GO:0002588,GO:0002588,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TREM2,1
GO:0002856,GO:0002856,negative regulation of natural killer cell mediated immune response to tumor cell,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,HAVCR2,1
GO:0002859,GO:0002859,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,HAVCR2,1
GO:0042488,GO:0042488,positive regulation of odontogenesis of dentin-containing tooth,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,CSF1,1
GO:0060557,GO:0060557,positive regulation of vitamin D biosynthetic process,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TNF,1
GO:0072564,GO:0072564,blood microparticle formation,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TNF,1
GO:0120190,GO:0120190,negative regulation of bile acid secretion,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TNF,1
GO:1901076,GO:1901076,positive regulation of engulfment of apoptotic cell,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TREM2,1
GO:1901980,GO:1901980,positive regulation of inward rectifier potassium channel activity,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TREM2,1
GO:1904093,GO:1904093,negative regulation of autophagic cell death,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TREM2,1
GO:1990267,GO:1990267,response to transition metal nanoparticle,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TNF,1
GO:1990268,GO:1990268,response to gold nanoparticle,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TNF,1
GO:2000332,GO:2000332,regulation of blood microparticle formation,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TNF,1
GO:2000334,GO:2000334,positive regulation of blood microparticle formation,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,TNF,1
GO:2000521,GO:2000521,negative regulation of immunological synapse formation,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,HAVCR2,1
GO:2000866,GO:2000866,positive regulation of estradiol secretion,1/20,2/18800,0.0021265843701509,0.0136807391261934,0.0055011153321184,SPP1,1
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,3/20,251/18800,0.0022660346018239,0.0144607589650532,0.0058147664481383,COL6A3/PLAUR/TNF,3
GO:0050708,GO:0050708,regulation of protein secretion,3/20,252/18800,0.0022917823151224,0.0145085342578866,0.0058339772081329,CCN3/TNF/TREM2,3
GO:0071216,GO:0071216,cellular response to biotic stimulus,3/20,256/18800,0.0023965997226891,0.0149341057229534,0.006005102297925,HAVCR2/TNF/TREM2,3
GO:0050766,GO:0050766,positive regulation of phagocytosis,2/20,71/18800,0.0025568670079625,0.0155816719421373,0.0062654929408614,TNF/TREM2,2
GO:0002437,GO:0002437,inflammatory response to antigenic stimulus,2/20,75/18800,0.0028479909899905,0.0166649760945276,0.006701096677406,TNF/TREM2,2
GO:0002534,GO:0002534,cytokine production involved in inflammatory response,2/20,75/18800,0.0028479909899905,0.0166649760945276,0.006701096677406,TNF/TREM2,2
GO:0010822,GO:0010822,positive regulation of mitochondrion organization,2/20,75/18800,0.0028479909899905,0.0166649760945276,0.006701096677406,PLAUR/TREM2,2
GO:1900015,GO:1900015,regulation of cytokine production involved in inflammatory response,2/20,75/18800,0.0028479909899905,0.0166649760945276,0.006701096677406,TNF/TREM2,2
GO:0043542,GO:0043542,endothelial cell migration,3/20,279/18800,0.0030573181134673,0.0166649760945276,0.006701096677406,CCN3/EPHA2/TNF,3
GO:0072659,GO:0072659,protein localization to plasma membrane,3/20,283/18800,0.0031825590549314,0.0166649760945276,0.006701096677406,EPHA2/TNF/TREM2,3
GO:0002439,GO:0002439,chronic inflammatory response to antigenic stimulus,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,TNF,1
GO:0002519,GO:0002519,natural killer cell tolerance induction,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,HAVCR2,1
GO:0010693,GO:0010693,negative regulation of alkaline phosphatase activity,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,TNF,1
GO:0014028,GO:0014028,notochord formation,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,EPHA2,1
GO:0048320,GO:0048320,axial mesoderm formation,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,EPHA2,1
GO:0060559,GO:0060559,positive regulation of calcidiol 1-monooxygenase activity,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,TNF,1
GO:1901491,GO:1901491,negative regulation of lymphangiogenesis,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,EPHA2,1
GO:1901647,GO:1901647,positive regulation of synoviocyte proliferation,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,TNF,1
GO:1905581,GO:1905581,positive regulation of low-density lipoprotein particle clearance,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,TREM2,1
GO:1990523,GO:1990523,bone regeneration,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,CCN3,1
GO:2001189,GO:2001189,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,HAVCR2,1
GO:2001272,GO:2001272,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,1/20,3/18800,0.0031882647783111,0.0166649760945276,0.006701096677406,TNF,1
GO:0120193,GO:0120193,tight junction organization,2/20,81/18800,0.0033125450677833,0.0172014186689794,0.0069168037707068,EPHA2/TNF,2
GO:0009914,GO:0009914,hormone transport,3/20,290/18800,0.0034092811274084,0.0175318696163494,0.0070496802736736,CCN3/SPP1/TNF,3
GO:0048678,GO:0048678,response to axon injury,2/20,83/18800,0.0034747685409813,0.017810991005224,0.0071619168230074,SPP1/TREM2,2
GO:0033627,GO:0033627,cell adhesion mediated by integrin,2/20,86/18800,0.0037249643410987,0.01891044197446,0.0076040133009818,CCN3/EPHA2,2
GO:0046849,GO:0046849,bone remodeling,2/20,88/18800,0.0038963138273605,0.019654738640241,0.0079032998937605,EPHA2/SPP1,2
GO:1903578,GO:1903578,regulation of ATP metabolic process,2/20,89/18800,0.003983348758262,0.0199670068671242,0.0080288650050308,TNF/TREM2,2
GO:0006909,GO:0006909,phagocytosis,3/20,310/18800,0.0041111169934176,0.0199794296118698,0.0080338602725348,MSR1/TNF/TREM2,3
GO:1901214,GO:1901214,regulation of neuron death,3/20,313/18800,0.0042234319784245,0.0199794296118698,0.0080338602725348,CSF1/TNF/TREM2,3
GO:0002835,GO:0002835,negative regulation of response to tumor cell,1/20,4/18800,0.0042488720403445,0.0199794296118698,0.0080338602725348,HAVCR2,1
GO:0002838,GO:0002838,negative regulation of immune response to tumor cell,1/20,4/18800,0.0042488720403445,0.0199794296118698,0.0080338602725348,HAVCR2,1
GO:0002941,GO:0002941,synoviocyte proliferation,1/20,4/18800,0.0042488720403445,0.0199794296118698,0.0080338602725348,TNF,1
GO:0045728,GO:0045728,respiratory burst after phagocytosis,1/20,4/18800,0.0042488720403445,0.0199794296118698,0.0080338602725348,TREM2,1
GO:0046136,GO:0046136,positive regulation of vitamin metabolic process,1/20,4/18800,0.0042488720403445,0.0199794296118698,0.0080338602725348,TNF,1
GO:0048319,GO:0048319,axial mesoderm morphogenesis,1/20,4/18800,0.0042488720403445,0.0199794296118698,0.0080338602725348,EPHA2,1
GO:0071603,GO:0071603,endothelial cell-cell adhesion,1/20,4/18800,0.0042488720403445,0.0199794296118698,0.0080338602725348,CCN3,1
GO:1901671,GO:1901671,positive regulation of superoxide dismutase activity,1/20,4/18800,0.0042488720403445,0.0199794296118698,0.0080338602725348,TNF,1
GO:1905242,GO:1905242,"response to 3,3',5-triiodo-L-thyronine",1/20,4/18800,0.0042488720403445,0.0199794296118698,0.0080338602725348,TNF,1
GO:1903035,GO:1903035,negative regulation of response to wounding,2/20,92/18800,0.0042498723781069,0.0199794296118698,0.0080338602725348,SPP1/TNF,2
GO:0002532,GO:0002532,production of molecular mediator involved in inflammatory response,2/20,97/18800,0.0047120319652396,0.0217026631674372,0.0087267838379877,TNF/TREM2,2
GO:1990868,GO:1990868,response to chemokine,2/20,97/18800,0.0047120319652396,0.0217026631674372,0.0087267838379877,CCL7/TREM2,2
GO:0019233,GO:0019233,sensory perception of pain,2/20,99/18800,0.0049031372376895,0.0223881754904849,0.0090024328592788,CCN3/TNF,2
GO:0042102,GO:0042102,positive regulation of T cell proliferation,2/20,103/18800,0.0052959679986202,0.0226140992367156,0.0090932782860364,CD276/HAVCR2,2
GO:0006710,GO:0006710,androgen catabolic process,1/20,5/18800,0.0053084071839489,0.0226140992367156,0.0090932782860364,SPP1,1
GO:0034239,GO:0034239,regulation of macrophage fusion,1/20,5/18800,0.0053084071839489,0.0226140992367156,0.0090932782860364,TREM2,1
GO:0034241,GO:0034241,positive regulation of macrophage fusion,1/20,5/18800,0.0053084071839489,0.0226140992367156,0.0090932782860364,TREM2,1
GO:0035509,GO:0035509,negative regulation of myosin-light-chain-phosphatase activity,1/20,5/18800,0.0053084071839489,0.0226140992367156,0.0090932782860364,TNF,1
GO:0060664,GO:0060664,epithelial cell proliferation involved in salivary gland morphogenesis,1/20,5/18800,0.0053084071839489,0.0226140992367156,0.0090932782860364,TNF,1
GO:0061889,GO:0061889,negative regulation of astrocyte activation,1/20,5/18800,0.0053084071839489,0.0226140992367156,0.0090932782860364,TREM2,1
GO:0110088,GO:0110088,hippocampal neuron apoptotic process,1/20,5/18800,0.0053084071839489,0.0226140992367156,0.0090932782860364,TREM2,1
GO:0110089,GO:0110089,regulation of hippocampal neuron apoptotic process,1/20,5/18800,0.0053084071839489,0.0226140992367156,0.0090932782860364,TREM2,1
GO:1902731,GO:1902731,negative regulation of chondrocyte proliferation,1/20,5/18800,0.0053084071839489,0.0226140992367156,0.0090932782860364,CCN3,1
GO:0035592,GO:0035592,establishment of protein localization to extracellular region,3/20,351/18800,0.0058106766471899,0.0243619134363715,0.009796085890416,CCN3/TNF/TREM2,3
GO:0070997,GO:0070997,neuron death,3/20,353/18800,0.0059028570535006,0.0244962672974238,0.0098501104630759,CSF1/TNF/TREM2,3
GO:0071692,GO:0071692,protein localization to extracellular region,3/20,359/18800,0.0061846981058043,0.0244962672974238,0.0098501104630759,CCN3/TNF/TREM2,3
GO:0090132,GO:0090132,epithelium migration,3/20,361/18800,0.0062804196008505,0.0244962672974238,0.0098501104630759,CCN3/EPHA2/TNF,3
GO:0002461,GO:0002461,tolerance induction dependent upon immune response,1/20,6/18800,0.0063668712358943,0.0244962672974238,0.0098501104630759,HAVCR2,1
GO:0002826,GO:0002826,negative regulation of T-helper 1 type immune response,1/20,6/18800,0.0063668712358943,0.0244962672974238,0.0098501104630759,HAVCR2,1
GO:0034238,GO:0034238,macrophage fusion,1/20,6/18800,0.0063668712358943,0.0244962672974238,0.0098501104630759,TREM2,1
GO:0061757,GO:0061757,leukocyte adhesion to arterial endothelial cell,1/20,6/18800,0.0063668712358943,0.0244962672974238,0.0098501104630759,TNF,1
GO:0070309,GO:0070309,lens fiber cell morphogenesis,1/20,6/18800,0.0063668712358943,0.0244962672974238,0.0098501104630759,EPHA2,1
GO:0070345,GO:0070345,negative regulation of fat cell proliferation,1/20,6/18800,0.0063668712358943,0.0244962672974238,0.0098501104630759,TREM2,1
GO:0071224,GO:0071224,cellular response to peptidoglycan,1/20,6/18800,0.0063668712358943,0.0244962672974238,0.0098501104630759,TREM2,1
GO:1900425,GO:1900425,negative regulation of defense response to bacterium,1/20,6/18800,0.0063668712358943,0.0244962672974238,0.0098501104630759,HAVCR2,1
GO:2001270,GO:2001270,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,1/20,6/18800,0.0063668712358943,0.0244962672974238,0.0098501104630759,TNF,1
GO:0002449,GO:0002449,lymphocyte mediated immunity,3/20,365/18800,0.0064745382230661,0.0248503411508503,0.0099924858921971,HAVCR2/TNF/TREM2,3
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3/20,370/18800,0.0067222267233616,0.0255541106780423,0.0102754762555541,HAVCR2/TNF/TREM2,3
GO:0051346,GO:0051346,negative regulation of hydrolase activity,3/20,371/18800,0.00677243924802,0.0255934129347541,0.0102912799519034,COL6A3/PLAUR/TNF,3
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,3/20,373/18800,0.0068735413237325,0.0258816520459976,0.0104071827974698,EPHA2/TNF/TREM2,3
GO:0071346,GO:0071346,cellular response to interferon-gamma,2/20,118/18800,0.0068934147396196,0.0258951206176256,0.0104125985988531,CCL7/TNF,2
GO:0002455,GO:0002455,humoral immune response mediated by circulating immunoglobulin,2/20,121/18800,0.0072361105014919,0.0263918510912614,0.0106123371947903,TNF/TREM2,2
GO:0010727,GO:0010727,negative regulation of hydrogen peroxide metabolic process,1/20,7/18800,0.0074242652220225,0.0263918510912614,0.0106123371947903,MMP3,1
GO:0031622,GO:0031622,positive regulation of fever generation,1/20,7/18800,0.0074242652220225,0.0263918510912614,0.0106123371947903,TNF,1
GO:0060558,GO:0060558,regulation of calcidiol 1-monooxygenase activity,1/20,7/18800,0.0074242652220225,0.0263918510912614,0.0106123371947903,TNF,1
GO:0071316,GO:0071316,cellular response to nicotine,1/20,7/18800,0.0074242652220225,0.0263918510912614,0.0106123371947903,TNF,1
GO:0090027,GO:0090027,negative regulation of monocyte chemotaxis,1/20,7/18800,0.0074242652220225,0.0263918510912614,0.0106123371947903,CCN3,1
GO:1900226,GO:1900226,negative regulation of NLRP3 inflammasome complex assembly,1/20,7/18800,0.0074242652220225,0.0263918510912614,0.0106123371947903,TREM2,1
GO:1903721,GO:1903721,positive regulation of I-kappaB phosphorylation,1/20,7/18800,0.0074242652220225,0.0263918510912614,0.0106123371947903,TNF,1
GO:0006911,GO:0006911,"phagocytosis, engulfment",2/20,128/18800,0.0080653043204577,0.0285429143991254,0.011477293922208,MSR1/TREM2,2
GO:0042590,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,1/20,8/18800,0.0084805901672442,0.0286107383773908,0.0115045663906967,IFI30,1
GO:0045760,GO:0045760,positive regulation of action potential,1/20,8/18800,0.0084805901672442,0.0286107383773908,0.0115045663906967,TNF,1
GO:0048318,GO:0048318,axial mesoderm development,1/20,8/18800,0.0084805901672442,0.0286107383773908,0.0115045663906967,EPHA2,1
GO:0060693,GO:0060693,regulation of branching involved in salivary gland morphogenesis,1/20,8/18800,0.0084805901672442,0.0286107383773908,0.0115045663906967,TNF,1
GO:0061044,GO:0061044,negative regulation of vascular wound healing,1/20,8/18800,0.0084805901672442,0.0286107383773908,0.0115045663906967,TNF,1
GO:0097527,GO:0097527,necroptotic signaling pathway,1/20,8/18800,0.0084805901672442,0.0286107383773908,0.0115045663906967,TNF,1
GO:0150094,GO:0150094,amyloid-beta clearance by cellular catabolic process,1/20,8/18800,0.0084805901672442,0.0286107383773908,0.0115045663906967,TREM2,1
GO:1901668,GO:1901668,regulation of superoxide dismutase activity,1/20,8/18800,0.0084805901672442,0.0286107383773908,0.0115045663906967,TNF,1
GO:0099024,GO:0099024,plasma membrane invagination,2/20,137/18800,0.0091914500912343,0.0304266285839825,0.0122347478059537,MSR1/TREM2,2
GO:0002420,GO:0002420,natural killer cell mediated cytotoxicity directed against tumor cell target,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,HAVCR2,1
GO:0010692,GO:0010692,regulation of alkaline phosphatase activity,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,TNF,1
GO:0031652,GO:0031652,positive regulation of heat generation,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,TNF,1
GO:0032815,GO:0032815,negative regulation of natural killer cell activation,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,HAVCR2,1
GO:0034351,GO:0034351,negative regulation of glial cell apoptotic process,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,TREM2,1
GO:0036480,GO:0036480,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,TREM2,1
GO:0060075,GO:0060075,regulation of resting membrane potential,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,TREM2,1
GO:0060392,GO:0060392,negative regulation of SMAD protein signal transduction,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,CCN3,1
GO:0090324,GO:0090324,negative regulation of oxidative phosphorylation,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,TNF,1
GO:1903376,GO:1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,TREM2,1
GO:1903960,GO:1903960,negative regulation of anion transmembrane transport,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,TNF,1
GO:1904238,GO:1904238,pericyte cell differentiation,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,EPHA2,1
GO:1905331,GO:1905331,negative regulation of morphogenesis of an epithelium,1/20,9/18800,0.0095358470955464,0.0304266285839825,0.0122347478059537,TNF,1
GO:0006979,GO:0006979,response to oxidative stress,3/20,433/18800,0.0103361924205749,0.0320525120774312,0.012888526270081,MMP3/TNF/TREM2,3
GO:0002291,GO:0002291,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,1/20,10/18800,0.0105900370299883,0.0320525120774312,0.012888526270081,HAVCR2,1
GO:0048102,GO:0048102,autophagic cell death,1/20,10/18800,0.0105900370299883,0.0320525120774312,0.012888526270081,TREM2,1
GO:1903980,GO:1903980,positive regulation of microglial cell activation,1/20,10/18800,0.0105900370299883,0.0320525120774312,0.012888526270081,TREM2,1
GO:2000347,GO:2000347,positive regulation of hepatocyte proliferation,1/20,10/18800,0.0105900370299883,0.0320525120774312,0.012888526270081,TNF,1
GO:0043535,GO:0043535,regulation of blood vessel endothelial cell migration,2/20,150/18800,0.0109349787063877,0.0327843040838679,0.0131827846569559,EPHA2/TNF,2
GO:0050673,GO:0050673,epithelial cell proliferation,3/20,443/18800,0.0109960467678471,0.0329053075595274,0.0132314409516963,CCN3/EPHA2/TNF,3
GO:0001660,GO:0001660,fever generation,1/20,11/18800,0.0116431609927022,0.0336381505770979,0.0135261219570723,TNF,1
GO:0031642,GO:0031642,negative regulation of myelination,1/20,11/18800,0.0116431609927022,0.0336381505770979,0.0135261219570723,TNF,1
GO:0042447,GO:0042447,hormone catabolic process,1/20,11/18800,0.0116431609927022,0.0336381505770979,0.0135261219570723,SPP1,1
GO:0071394,GO:0071394,cellular response to testosterone stimulus,1/20,11/18800,0.0116431609927022,0.0336381505770979,0.0135261219570723,SPP1,1
GO:0071492,GO:0071492,cellular response to UV-A,1/20,11/18800,0.0116431609927022,0.0336381505770979,0.0135261219570723,MMP3,1
GO:1901856,GO:1901856,negative regulation of cellular respiration,1/20,11/18800,0.0116431609927022,0.0336381505770979,0.0135261219570723,TNF,1
GO:1903799,GO:1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA,1/20,11/18800,0.0116431609927022,0.0336381505770979,0.0135261219570723,TNF,1
GO:0010459,GO:0010459,negative regulation of heart rate,1/20,12/18800,0.0126952200048981,0.0358307363903784,0.0144077751574706,TNF,1
GO:0051798,GO:0051798,positive regulation of hair follicle development,1/20,12/18800,0.0126952200048981,0.0358307363903784,0.0144077751574706,TNF,1
GO:0070341,GO:0070341,fat cell proliferation,1/20,12/18800,0.0126952200048981,0.0358307363903784,0.0144077751574706,TREM2,1
GO:0140052,GO:0140052,cellular response to oxidised low-density lipoprotein particle stimulus,1/20,12/18800,0.0126952200048981,0.0358307363903784,0.0144077751574706,TREM2,1
GO:0034250,GO:0034250,positive regulation of cellular amide metabolic process,2/20,167/18800,0.0134177926702073,0.0376029498288526,0.0151203938565225,IFNGR1/TNF,2
GO:0051048,GO:0051048,negative regulation of secretion,2/20,167/18800,0.0134177926702073,0.0376029498288526,0.0151203938565225,CCN3/TNF,2
GO:0042362,GO:0042362,fat-soluble vitamin biosynthetic process,1/20,13/18800,0.01374621508686,0.0378556945806249,0.0152220241863067,TNF,1
GO:1905155,GO:1905155,positive regulation of membrane invagination,1/20,13/18800,0.01374621508686,0.0378556945806249,0.0152220241863067,TREM2,1
GO:1905907,GO:1905907,negative regulation of amyloid fibril formation,1/20,13/18800,0.01374621508686,0.0378556945806249,0.0152220241863067,TREM2,1
GO:0031214,GO:0031214,biomineral tissue development,2/20,170/18800,0.0138792479974858,0.0381559257231918,0.0153427491066725,KLK4/SPP1,2
GO:0051099,GO:0051099,positive regulation of binding,2/20,171/18800,0.0140345975431769,0.0384499577519105,0.0154609813225197,PLAUR/SPON1,2
GO:0110148,GO:0110148,biomineralization,2/20,172/18800,0.0141907099225224,0.0387440516613197,0.0155792384210003,KLK4/SPP1,2
GO:0048659,GO:0048659,smooth muscle cell proliferation,2/20,173/18800,0.0143475835081875,0.0391051632838935,0.0157244437834609,CCN3/TNF,2
GO:0042129,GO:0042129,regulation of T cell proliferation,2/20,174/18800,0.0145052166751351,0.0391848657825859,0.0157564926832696,CD276/HAVCR2,2
GO:0044089,GO:0044089,positive regulation of cellular component biogenesis,3/20,494/18800,0.0147408545282764,0.0391848657825859,0.0157564926832696,EPHA2/MMP3/TNF,3
GO:0001771,GO:0001771,immunological synapse formation,1/20,14/18800,0.0147961472579498,0.0391848657825859,0.0157564926832696,HAVCR2,1
GO:0050966,GO:0050966,detection of mechanical stimulus involved in sensory perception of pain,1/20,14/18800,0.0147961472579498,0.0391848657825859,0.0157564926832696,TNF,1
GO:0070141,GO:0070141,response to UV-A,1/20,14/18800,0.0147961472579498,0.0391848657825859,0.0157564926832696,MMP3,1
GO:2001171,GO:2001171,positive regulation of ATP biosynthetic process,1/20,14/18800,0.0147961472579498,0.0391848657825859,0.0157564926832696,TREM2,1
GO:0010817,GO:0010817,regulation of hormone levels,3/20,496/18800,0.0149008101064683,0.0393312080717245,0.0158153378818434,CCN3/SPP1/TNF,3
GO:0050777,GO:0050777,negative regulation of immune response,2/20,179/18800,0.0153047195133108,0.0399986830701495,0.0160837339760728,HAVCR2/TREM2,2
GO:0010832,GO:0010832,negative regulation of myotube differentiation,1/20,15/18800,0.0158450175366064,0.0403489308744672,0.0162245709256412,CCN3,1
GO:0051956,GO:0051956,negative regulation of amino acid transport,1/20,15/18800,0.0158450175366064,0.0403489308744672,0.0162245709256412,TNF,1
GO:0030308,GO:0030308,negative regulation of cell growth,2/20,186/18800,0.016455473629681,0.0417029467265759,0.0167690296201064,CCN3/SPP1,2
GO:0034349,GO:0034349,glial cell apoptotic process,1/20,16/18800,0.0168928269403469,0.04194172188783,0.0168650426855108,TREM2,1
GO:0045780,GO:0045780,positive regulation of bone resorption,1/20,16/18800,0.0168928269403469,0.04194172188783,0.0168650426855108,SPP1,1
GO:0002544,GO:0002544,chronic inflammatory response,1/20,17/18800,0.017939576485768,0.0435205908944816,0.0174999163147629,TNF,1
GO:0036342,GO:0036342,post-anal tail morphogenesis,1/20,17/18800,0.017939576485768,0.0435205908944816,0.0174999163147629,EPHA2,1
GO:0060252,GO:0060252,positive regulation of glial cell proliferation,1/20,17/18800,0.017939576485768,0.0435205908944816,0.0174999163147629,TNF,1
GO:0071732,GO:0071732,cellular response to nitric oxide,1/20,17/18800,0.017939576485768,0.0435205908944816,0.0174999163147629,MMP3,1
GO:1901550,GO:1901550,regulation of endothelial cell development,1/20,17/18800,0.017939576485768,0.0435205908944816,0.0174999163147629,TNF,1
GO:1903140,GO:1903140,regulation of establishment of endothelial barrier,1/20,17/18800,0.017939576485768,0.0435205908944816,0.0174999163147629,TNF,1
GO:0060965,GO:0060965,negative regulation of miRNA-mediated gene silencing,1/20,18/18800,0.0189852671885462,0.045570219149896,0.0183240853393308,TNF,1
GO:0009612,GO:0009612,response to mechanical stimulus,2/20,201/18800,0.0190425585371497,0.045570219149896,0.0183240853393308,LTBR/TNF,2
GO:0042098,GO:0042098,T cell proliferation,2/20,204/18800,0.0195794500760802,0.0465744703157056,0.0187279013491659,CD276/HAVCR2,2
GO:0071800,GO:0071800,podosome assembly,1/20,19/18800,0.0200299000634387,0.0465995771607674,0.0187379969769705,TNF,1
GO:1902170,GO:1902170,cellular response to reactive nitrogen species,1/20,19/18800,0.0200299000634387,0.0465995771607674,0.0187379969769705,MMP3,1
GO:0002643,GO:0002643,regulation of tolerance induction,1/20,20/18800,0.021073476124284,0.0476326508698254,0.0191534027213302,HAVCR2,1
GO:0042359,GO:0042359,vitamin D metabolic process,1/20,20/18800,0.021073476124284,0.0476326508698254,0.0191534027213302,TNF,1
GO:0042953,GO:0042953,lipoprotein transport,1/20,20/18800,0.021073476124284,0.0476326508698254,0.0191534027213302,MSR1,1
GO:0061484,GO:0061484,hematopoietic stem cell homeostasis,1/20,20/18800,0.021073476124284,0.0476326508698254,0.0191534027213302,CCN3,1
GO:0097062,GO:0097062,dendritic spine maintenance,1/20,20/18800,0.021073476124284,0.0476326508698254,0.0191534027213302,TREM2,1
GO:0044706,GO:0044706,multi-multicellular organism process,2/20,213/18800,0.0212283153119775,0.0479144787368357,0.0192667275633528,HAVCR2/SPP1,2
GO:0050803,GO:0050803,regulation of synapse structure or activity,2/20,215/18800,0.0216024300879276,0.0486897324960524,0.0195784622073491,TNF/TREM2,2
GO:0050866,GO:0050866,negative regulation of cell activation,2/20,216/18800,0.0217905282955921,0.0489055783357285,0.0196652552414873,HAVCR2/TREM2,2
GO:0003085,GO:0003085,negative regulation of systemic arterial blood pressure,1/20,21/18800,0.0221159963840025,0.0491500954603916,0.0197635771882069,TNF,1
GO:0044872,GO:0044872,lipoprotein localization,1/20,21/18800,0.0221159963840025,0.0491500954603916,0.0197635771882069,MSR1,1
GO:0071731,GO:0071731,response to nitric oxide,1/20,21/18800,0.0221159963840025,0.0491500954603916,0.0197635771882069,MMP3,1
